Cite
PD40-07 CLINICAL OUTCOMES AND ADVERSE EVENTS AFTER FIRST-LINE TREATMENT IN METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
MLA
Luigi Nocera, et al. “Pd40-07 Clinical Outcomes and Adverse Events After First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis.” Journal of Urology, vol. 206, Sept. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........36c9ee7b7015905dddc8c52e28d99336&authtype=sso&custid=ns315887.
APA
Luigi Nocera, Pierre Karakiewicz, Mike Wenzel, Shahrokh Shariat, Fred Saad, Felix Chun, Alberto Briganti, Anil Kapoor, Aly-Khan Lalani, Alberto Martini, Alessandro Larcher, Luigi Candela, Antony Pellegrino, Giuseppe Fallara, Gianfranco Baiamonte, Cristina Giancristofaro, Roberto Bertini, Andrea Necchi, Francesco Montorsi, & Umberto Capitanio. (2021). Pd40-07 Clinical Outcomes and Adverse Events After First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis. Journal of Urology, 206.
Chicago
Luigi Nocera, Pierre Karakiewicz, Mike Wenzel, Shahrokh Shariat, Fred Saad, Felix Chun, Alberto Briganti, et al. 2021. “Pd40-07 Clinical Outcomes and Adverse Events After First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis.” Journal of Urology 206 (September). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........36c9ee7b7015905dddc8c52e28d99336&authtype=sso&custid=ns315887.